# Pharmacy Times * **Definition:** Pharmacy Times is a publication that provides news, information, and resources for pharmacists and pharmacy professionals, focusing on clinical updates, industry trends, and practice management. * **Taxonomy:** Key Sources / Healthcare Publications / Pharmacy Times ## News * Selected news from the source **Pharmacy Times**, for healthcare technology leaders * 3.4K news items are in the system for this source * Posts have been filtered for tech-related keywords | Date | Title | Topics | | --- | --- | --- | | 5/28/2025 | [**The Intersection of Pharmacists and Biotechnology: Advancements and Challenges**](https://www.pharmacytimes.com/view/the-intersection-of-pharmacists-and-biotechnology-advancements-and-challenges) | [[Dermatology]]; [[Neurology]]; [[Access to Treatments]] | | 5/22/2025 | [**Navigating the Complexities of the Cell and Gene Therapy Landscape: Insights From the 2025 Advanced Therapies Report**](https://www.pharmacytimes.com/view/navigating-the-complexities-of-the-cell-and-gene-therapy-landscape-insights-from-the-2025-advanced-therapies-report) | [[Cell Therapy]]; [[Negotiations]]; [[Regenerative Medicine]] | | 5/12/2025 | [**Children Born to Mothers With Cardiometabolic Issues Before or During Pregnancy Face Increased Risk of Childhood, Adolescent Hypertension**](https://www.pharmacytimes.com/view/children-born-to-mothers-with-cardiometabolic-issues-before-or-during-pregnancy-face-increased-risk-of-childhood-adolescent-hypertension) | [[Adolescent Medicine]]; [[Metabolic Health]]; [[Maternal Health]] | | 5/7/2025 | [**AI at the Counter: How Artificial Intelligence Is Shaping the Future of Pharmacy Practice**](https://www.pharmacytimes.com/view/ai-at-the-counter-how-artificial-intelligence-is-shaping-the-future-of-pharmacy-practice) | [[HTI-2 Proposed Rule]]; [[Clinical Decision Support]]; [[Data Privacy Concerns]] | | 5/5/2025 | [**Pharmacist-Led Care in Palliative Settings: Using Anticholinergics Thoughtfully and Compassionately**](https://www.pharmacytimes.com/view/pharmacist-led-care-in-palliative-settings-using-anticholinergics-thoughtfully-and-compassionately) | [[Palliative Care]]; [[Pharma]] | | 4/23/2025 | [**Study Links PAK5 to Poor Outcomes and Drug Resistance in HER2-Positive Breast Cancer**](https://www.pharmacytimes.com/view/study-links-pak5-to-poor-outcomes-and-drug-resistance-in-her2-positive-breast-cancer) | [[Pharma]]; [[Dermatology]]; [[Pain Management]] | | 4/22/2025 | [**Where Is Pharmacy Technician CE in Oncology?**](https://www.pharmacytimes.com/view/where-is-pharmacy-technician-ce-in-oncology-) | [[Retention]]; [[Medication Errors]]; [[Collaboration]] | | 4/22/2025 | [**Pharmacy Technicians as Non-Pharmacist Preceptors for a Sterile Compounding Rotation**](https://www.pharmacytimes.com/view/pharmacy-technicians-as-non-pharmacist-preceptors-for-a-sterile-compounding-rotation) | [[Health]]; [[Pharma]]; [[Training]] | | 4/18/2025 | [**Advances in the Management of HR+/HER2- Ultralow and -Low Metastatic Breast Cancer: New Horizons and Treatment Frontiers**](https://www.pharmacytimes.com/view/advances-in-the-management-of-hr-her2--ultralow-and--low-metastatic-breast-cancer-new-horizons-and-treatment-frontiers) | [[Patient Monitoring]]; [[Healthcare]]; [[Biosimilars]] | | 4/17/2025 | [**Pharmacist Spotlight: Adenike Atanda-Oshikoya, PharmD, BCACP, CDCES, CTTS**](https://www.pharmacytimes.com/view/pharmacist-spotlight-adenike-atanda-oshikoya-pharmd-bcacp-cdces-ctts) | [[Mentoring]]; [[Population Health]]; [[Health Economics]] | | 4/17/2025 | [**NCPA Raises Concerns About Implementation of Medicare Drug Price Negotiation Program**](https://www.pharmacytimes.com/view/ncpa-raises-concerns-about-implementation-of-medicare-drug-price-negotiation-program) | [[Drug Price Negotiation]]; [[Pharma]]; [[Negotiation]] | | 4/15/2025 | [**Outcomes of Pharmacist-Driven Clinical Interventions in a Medically Integrated Oncology Specialty Pharmacy Practice**](https://www.pharmacytimes.com/view/outcomes-of-pharmacist-driven-clinical-interventions-in-a-medically-integrated-oncology-specialty-pharmacy-practice) | [[Pharma]]; [[Clinical Trials]]; [[Oncology]] | | 4/14/2025 | [**Community Pharmacies Actively Advance Clinical Trial Access**](https://www.pharmacytimes.com/view/community-pharmacies-actively-advance-clinical-trial-access) | [[Pharma]]; [[Training]]; [[Clinical Trials]] | | 4/14/2025 | [**Driving Clinical Pharmacy Development With Data-Driven Metrics and Insights**](https://www.pharmacytimes.com/view/driving-clinical-pharmacy-development-with-data-driven-metrics-and-insights) | [[Pharma]] | | 4/11/2025 | [**Measuring Impact Without Adding Burden: Finding Meaning in Metrics**](https://www.pharmacytimes.com/view/measuring-impact-without-adding-burden-finding-meaning-in-metrics) | [[Patient Education]]; [[Hematology]]; [[Pharma]] | | 4/11/2025 | [**Study Finds 4-Factor Prothrombin Complex Concentrate Offers Superior Hemostatic Efficacy to Frozen Plasma During Cardiac Surgery**](https://www.pharmacytimes.com/view/study-finds-4-factor-prothrombin-complex-concentrate-offers-superior-hemostatic-efficacy-to-frozen-plasma-during-cardiac-surgery) | [[Cardiology]]; [[Cardiac Surgery]]; [[Health Research]] | | 4/9/2025 | [**AAN 2025: Precision Medicine and Pharmacogenomics in Neurological Care**](https://www.pharmacytimes.com/view/aan-2025-precision-medicine-and-pharmacogenomics-in-neurological-care) | [[AI in Clinical Trials]]; [[Strategy]]; [[CRISPR Technology]] | | 4/7/2025 | [**AAN 2025: Enhanced Care, Economic Value Tied to Specialty Pharmacist Integration in Neurology Clinics**](https://www.pharmacytimes.com/view/aan-2025-enhanced-care-economic-value-tied-to-specialty-pharmacist-integration-in-neurology-clinics) | [[Pharma]]; [[Pediatrics]]; [[Womens Health]] | | 4/4/2025 | [**New Poll Shows COVID-19 Pandemic Changed Survey Takers' Perspectives on Vaccinations**](https://www.pharmacytimes.com/view/new-poll-shows-covid-19-pandemic-changed-survey-takers-perspectives-on-vaccinations) | [[Public Health]]; [[Disinformation Security]]; [[Infectious Disease]] | | 3/18/2025 | [**Artificial Intelligence Has Implications for Medication Safety**](https://www.pharmacytimes.com/view/artificial-intelligence-has-implications-for-medication-safety) | [[AI in Medical Diagnostics]]; [[Ethical Concerns in AI]]; [[AI in Clinical Documentation]] | | 3/14/2025 | [**As Biosimilar Substitutions Become More Common, Education and Patient Counseling Are Paramount**](https://www.pharmacytimes.com/view/as-biosimilar-substitutions-become-more-common-education-and-patient-counseling-are-paramount) | [[Biosimilars]]; [[Patient Access]]; [[Compliance]] | | 3/13/2025 | [**National Institutes of Health Limits Grants for Vaccine Hesitancy Studies, Raising Questions About Future of Research**](https://www.pharmacytimes.com/view/national-institutes-of-health-limits-grants-for-vaccine-hesitancy-studies-raising-questions-about-future-of-research) | [[Vaccine Hesitancy]] | | 3/7/2025 | [**Experts Raise Alarm Over Vaccine Hesitancy and Misinformation as the Measles Outbreak Spreads**](https://www.pharmacytimes.com/view/experts-raise-alarm-over-vaccine-hesitancy-and-misinformation-as-the-measles-outbreak-spreads) | [[Health]]; [[Vaccine Hesitancy]] | | 3/6/2025 | [**Beyond the Bed: Transitioning Cancer Care From Hospitals to Outpatient Infusion Centers**](https://www.pharmacytimes.com/view/beyond-the-bed-transitioning-cancer-care-from-hospitals-to-outpatient-infusion-centers) | [[Health]]; [[Ambulatory Surgical Centers]]; [[Oncology]] | | 3/5/2025 | [**Medication Management and Supply Chain Still Underwater: Challenges and Future Trends in Health Care**](https://www.pharmacytimes.com/view/medication-management-and-supply-chain-still-underwater-challenges-and-future-trends-in-health-care) | [[Regulatory Requirements]]; [[DSCSA Mandate]]; [[Medication Management]] | ## Recent Stories (Some LLM-derived content — please confirm with above primary sources) ### Topics Covered - **Dedicated Infusion Centers**: Enhance patient care for cancer patients by providing specialized treatments, shorter wait times, and a personalized environment. - **Specialty Pharmacies**: Play a crucial role in managing complex cancer treatments and ensuring medication consistency. - **CMR Imaging**: Valuable for diagnosing and monitoring recurrent pericarditis, with the RESONANCE registry enhancing understanding and management. - **Precision Medicine**: Expected to transform healthcare through integrated multi-omic data, impacting drug development and patient assessment. - **Continuing Education for Pharmacy Technicians**: Essential for skill enhancement and professional growth, improving patient care in specialized fields like oncology. - **Asembia AXS25 Conference**: Highlighted financial struggles of specialty pharmacies and the importance of balancing innovation with affordability. - **Digital Pharmacy Solutions**: Enhancing patient care through technology, as discussed by HealthDyne representatives at Asembia's AXS25 Summit. - **Artificial Intelligence in Pharmacy**: Transforming practice by streamlining workflows and enhancing patient care, while raising concerns about job security and data privacy. - **Chronic Kidney Disease Detection**: Innovative breath sensor technology shows promise for noninvasive CKD monitoring. - **Maternal Cardiometabolic Health**: Influences childhood hypertension risk, emphasizing the need for early intervention. - **CVS Health Formulary Changes**: Impacting patient access to weight management medications, particularly Zepbound and Wegovy. - **FDA Approval of Lumipulse Test**: A noninvasive method for detecting Alzheimer's disease, showing high accuracy compared to traditional methods. - **Impact of COVID-19 on Pharmacy Students**: Adverse effects on cognitive function and social engagement, highlighting the importance of community support. - **RSV Vaccination**: Pharmacists' role in enhancing vaccination efforts through collaboration and patient education. - **Novel Nonstatin Therapies**: Discussed for treating hyperlipidemia, emphasizing the urgency of treatment post-coronary events. - **Peer Exchange on Real-World Data**: Importance of supportive care options and ongoing education for pharmacists. - **Cell and Gene Therapies**: Pharmacists' growing responsibilities in managing complexities and ensuring patient access. - **Infusion-Related Reactions Management**: Importance of standardized protocols in improving patient outcomes for NSCLC treatment. - **Chronic Graft-Vs-Host Disease Management**: Pharmacist-led interventions addressing unmet needs and improving care coordination. - **Luspatercept**: Effective treatment for anemia post-allogeneic hematopoietic stem cell transplantation, with high erythroid response and favorable safety profile. ### Organizations Mentioned - **CVS Health**: A healthcare company that manages pharmacy benefits and formulary decisions. - **FDA**: The U.S. Food and Drug Administration, responsible for approving medical tests and treatments. - **CDC**: Centers for Disease Control and Prevention, providing guidelines for public health. - **HealthDyne**: A company focused on digital pharmacy solutions to enhance patient care. - **Asembia**: A conference highlighting issues in specialty pharmacy and healthcare. - **AAN**: American Academy of Neurology, focusing on advancements in neurology and patient care. - **SGO**: Society of Gynecologic Oncology, addressing women's cancer and healthcare disparities. - **NIH**: National Institutes of Health, supporting medical research and advancements. - **OptumRx**: Pharmacy benefit manager utilizing AI for improved patient outcomes. - **CVS Caremark**: Pharmacy benefit manager implementing AI-driven tools in medication management. - **Gladstone Institute**: Research institute focusing on neurological diseases and AI applications. - **Precision Medicine World Conference**: An event focusing on advancements in precision medicine and pharmacogenomics. - **University of Kansas Cancer Center**: An institution involved in cancer research and treatment. - **ASTCT**: American Society for Transplantation and Cellular Therapy, focusing on transplantation and cellular therapy education. - **CIBMTR**: Center for International Blood and Marrow Transplant Research, involved in research and data collection for blood and marrow transplants. - **McKesson**: A healthcare company that provides pharmaceuticals and medical supplies, involved in community health initiatives. - **University of Houston College of Pharmacy**: An academic institution focused on pharmacy education and research. - **Lumanity**: A company involved in health education and awareness initiatives. - **Indian Health Service**: A federal health program for American Indians and Alaska Natives.